Xenon Pharmaceuticals (FRA:XP0) Short-Term Capital Lease Obligation : €1.22 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals Short-Term Capital Lease Obligation?

Xenon Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.22 Mil.

Xenon Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€1.17 Mil) to Dec. 2023 (€1.19 Mil) and increased from Dec. 2023 (€1.19 Mil) to Mar. 2024 (€1.22 Mil).

Xenon Pharmaceuticals's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (€0.54 Mil) to Dec. 2022 (€0.46 Mil) but then increased from Dec. 2022 (€0.46 Mil) to Dec. 2023 (€1.19 Mil).

Xenon Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Xenon Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals Short-Term Capital Lease Obligation Chart

Xenon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.15

0.22

0.54

0.46

1.19

Xenon Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.12	1.13	1.17	1.19	1.22

Xenon Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Xenon Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Xenon Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Xenon Pharmaceuticals (FRA:XP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

XENE:USA

Address

200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8

Website

https://www.xenon-pharma.com

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Xenon Pharmaceuticals (FRA:XP0) Headlines

No Headlines